参考文献/References:
[1] Mao SH,Zhu CH,Nie Y,et al.Levobupivacaine induces ferroptosis by miR-489-3p/SLC7A11 signaling in gastric cancer[J].Front Pharmacol,2021,12:681338.
[2] Sun X,Niu X,Chen R,et al.Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis[J].Hepatology,2016,64(2):488-500.
[3] 刘湘慧,斯 韬,梁 婷,等.铁死亡发生机制及其在肝细胞癌中的作用研究进展[J].陕西医学杂志,2023,52(3):354-357.
[4] Manz DH,Blanchette NL,Paul BT,et al.Iron and cancer:Recent insights[M].Ann N Y Acad Sci,2016,1368(1):149-161.
[5] 罗少翔,何乾超,高玉广.铁死亡相关通路与癫痫关系研究进展[J].陕西医学杂志,2022,51(11):1462-封3.
[6] Yang WS,Sriramaratnam R,Welsch ME,et al.Regulation of ferroptotic cancer cell death by GPX4[J].Cell,2014,156(1-2):317-331.
[7] Ishimoto T,Nagano O,Yae T,et al.CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-)and thereby promotes tumor growth[J].Cancer Cell,2011,19(3):387-400.
[8] Huang Y,Dai Z,Barbacioru C,et al.Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance[J].Cancer Res,2005,65(16):7446-7454.
[9] Polewski MD,Reveron-Thornton RF,Cherryholmes GA,et al.Increased expression of system xc- in glioblastoma confers an altered metabolic state and temozolomide resistance[J].Mol Cancer Res,2016,14(12):1229-1242.
[10] Okazaki S,Shintani S,Hirata Y,et al.Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells[J].Oncotarget,2018,9(73):33832-33843.
[11] Fu D,Wang C,Yu L,et al.Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling[J].Cell Mol Biol Lett,2021,26(1):26.
[12] Fotiadis D,Kanai Y,Palacín M.The SLC3 and SLC7 families of amino acid transporters[J].Mol Aspects Med,2013,34(2-3):139-158.
[13] Ahmed I,Manno FAM,Manno SHC,et al.Detection of lithium in breast milk and in situ elemental analysis of the mammary gland[J].Biomed Opt Express,2018,9(9):4184-4195.
[14] Wang J,Wang T,Zhang Y,et al.CPEB1 enhances erastin-induced ferroptosis in gastric cancer cells by suppressing twist1 expression[J].IUBMB Life,2021,73(9):1180-1190.
[15] Stockwell BR,Friedmann AJP,Bayir H,et al.Ferroptosis:A regulated cell death nexus linking metabolism,redox biology,and disease[J].Cell,2017,171(2):273-285.
[16] Zhao L,Peng Y,He S,et al.Apatinib induced ferroptosis by lipid peroxidation in gastric cancer[J].Gastric Cancer,2021,24(3):642-654.
[17] Cai S,Fu S,Zhang W,et al.SIRT6 silencing overcomes resistance to sorafenib by promoting ferroptosis in gastric cancer[J].Biochem Biophys Res Commun,2021,577:158-164.
[18] Yang L,Shi P,Zhao G,et al.Targeting cancer stem cell pathways for cancer therapy[J].Signal Transduct Target Ther,2020,5(1):8.
[19] Ni H,Qin H,Sun C,et al.MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis[J].Stem Cell Res Ther,2021,12(1):325.
[20] Zhang H,Wang M,He Y,et al.Chemotoxicity-induced exosomal lncFERO regulates ferroptosis and stemness in gastric cancer stem cells[J].Cell Death Dis,2021,12(12):1116.
[21] Tsukada M,Ohsumi Y.Isolation and characterization of autophagy-defective mutants of saccharomyces cerevisiae[J].FEBS Lett,1993,333(1-2):169-174.
[22] 林增海,陆 军,王凯松.槲皮素对5-FU诱导的结直肠癌SW480细胞耐药及自噬调控机制研究[J].陕西中医,2021,42(10):1338-1343.
[23] Liu X,Ma B,Chen M,et al.Prognostic autophagy-related genes of gastric cancer patients on chemotherapy[J].Front Genet,2021,12:720849.
[24] Kang MR,Kim MS,Oh JE,et al.Frameshift mutations of autophagy-related genes ATG2B,ATG5,ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability[J].J Pathol,2009,217(5):702-706.
[25] Tanaka S,Nagashima H,Uotani T,et al.Autophagy-related genes in helicobacter pylori infection[J].Helicobacter,2017,22(3):10.
[26] An M,Ryu DR,Won Park J,et al.ULK1 prevents cardiac dysfunction in obesity through autophagy-meditated regulation of lipid metabolism[J].Cardiovasc Res,2017,113(10):1137-1147.
[27] Chen MB,Ji XZ,Liu YY,et al.Ulk1 over-expression in human gastric cancer is correlated with patients' T classification and cancer relapse[J].Oncotarget,2017,8(20):33704-33712.
[28] Motoo I,Nanjo S,Ando T,et al.Methylation silencing of ULK2 via epithelial-mesenchymal transition causes transformation to poorly differentiated gastric cancers[J].Gastric Cancer,2022,25(2):325-335.
[29] Zheng HC,Zhao S,Xue H,et al.The roles of Beclin 1 expression in gastric cancer:A marker for carcinogenesis,aggressive behaviors and favorable prognosis,and a target of gene therapy[J].Front Oncol,2020,10:613679.
[30] Zhao J,Lan W,Peng J,et al.Babao dan reverses multiple-drug resistance in gastric cancer cells via triggering apoptosis and autophagy and inhibiting PI3K/AKT/mTOR signaling[J].Evid Based Complement Alternat Med,2021,2021:5631942.
[31] 姚 婷,万 明.基于Akt/mTOR通路观察补中益气颗粒对实验性自身免疫性甲状腺炎大鼠的保护作用[J].陕西中医,2023,44(2):159-164.
[32] Xu W,Wei Q,Han M.CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer[J].Int J Biol Sci,2018,14(9):1054-1066.
[33] Wang C,Jiang J,Ji J.PKM2 promotes cell migration and inhibits autophagy by mediating PI3K/AKT activation and contributes to the malignant development of gastric cancer[J].Sci Rep,2017,7(1):2886.
[34] Yu Y,Hou L,Song H,et al.Akt/AMPK/mTOR pathway was involved in the autophagy induced by vitamin E succinate in human gastric cancer SGC-7901 cells[J].Mol Cell Biochem,2017,424(1-2):173-183.
[35] Wang LL,Zhang L,Cui XF.Downregulation of long noncoding RNA LINC01419 inhibits cell migration,invasion,and tumor growth and promotes autophagy via inactivation of the PI3K/Akt1/mTOR pathway in gastric cancer[J].Ther Adv Med Oncol,2019,11:1758835919874651.
[36] Liu SJ,Yang YB,Zhou JX,et al.A novel ferroptosis-related gene risk signature for predicting prognosis and immunotherapy response in gastric cancer[J].Dis Markers,2021,2021:2385406.
相似文献/References:
[1]侯洁心 ,郭萍△.免疫组化标志物Her2和肿瘤标志物在胃癌诊断中的价值分析*[J].陕西医学杂志,2019,(1):121.
HOU Jiexin,GUO Ping..The value of immunohistochemical marker Her2 andtumor markers in the diagnosis of gastric cancer[J].,2019,(9):121.
[2]唐亚荣.循环热灌注化疗联合替吉奥及热疗治疗老年胃癌癌性腹水临床研究*[J].陕西医学杂志,2019,(4):435.
TANG Yarong..Clinical effect analysis of combined therapy with tiago and hyperthermia in the treatment of malignant ascites in elderly patients with gastric cancer[J].,2019,(9):435.
[3]刘国庆,闫 龙△,高 任.1.5T磁共振扩散加权成像在胃癌淋巴结转移诊断中的应用价值*[J].陕西医学杂志,2019,(4):456.
LIU Guoqing,YAN Long,GAO Ren..1.5T magnetic resonance diffusion weighted imaging in the diagnosis of lymph node metastasis of gastric cancer[J].,2019,(9):456.
[4]胡乃军,王海龙.胃腺癌组织中MMP11、MMP12和VEGFD的表达及临床意义[J].陕西医学杂志,2019,(5):554.
[5]米志宽,赵菊梅.抑癌基因甲基化与胃癌关系研究进展*[J].陕西医学杂志,2019,(5):679.
MI Zhikuan,ZHAO Jumei..Research progress of relationships between tumor suppressor gene methylation and gastric cancer[J].,2019,(9):679.
[6]石颖鹏,王敏娟,李程亮.肠化生相关分子与胃癌的发生和进展研究概况[J].陕西医学杂志,2019,(7):958.
SHI Yingpeng,WANG Minjuan,LI Chengliang,et al.Intestinal metaplasia-related molecules and the occurrence and progress of gastric cancer[J].,2019,(9):958.
[7]郭小艳,于桂萍.抗幽门螺杆菌疗法联合新辅助化疗对胃癌术后疗效及患者血清VEGF、bFGF的影响[J].陕西医学杂志,2019,(8):1010.
GUO Xiaoyan,YU Guiping..Effect of anti-Helicobacter pylori therapy combined with neoadjuvant chemotherapy on serum VEGF and bFGF in postoperative patients with gastric cancer[J].,2019,(9):1010.
[8]柯东平,毛俊倩,郭甲民,等.SCNN1B与胃癌细胞上皮间质转化相关性实验研究*[J].陕西医学杂志,2019,(9):1115.
KE Dongping,MAO Junqian,GUO Jiamin,et al.Research on the correlation between SCNN1B and〖JZ〗 epithelialmesenchymal transformation in gastric cancer cells[J].,2019,(9):1115.
[9]王小林,马任远,张 哲.腹腔镜手术治疗老年进展期胃癌50例临床疗效分析[J].陕西医学杂志,2019,(10):1360.
[10]刘维帅,郭晓宁,杨 洋,等.胃癌病理类型及临床预后与血清miR-133a和DKK-1相关性分析[J].陕西医学杂志,2020,49(6):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]
LIU Weishuai,GUO Xiaoning,YANG Yang,et al.Correlation of pathological types and clinical prognosis of gastric cancer with serum miR-133a and DKK-1[J].,2020,49(9):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]